Technology Times New Jersey
SEE OTHER BRANDS

Reporting on science and technology news in New Jersey

Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on September 24, 2025

uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
uniQure Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease
Mavenir von Iridium für die Bereitstellung des Kernnetzwerks für globale satellitengestützte NB-IoT- und D2D-Dienste ausgewählt
Mavenir seleccionada por Iridium para desplegar la red central de servicios globales de NB-IoT y D2D basados en satélites
Mavenir choisie par Iridium pour fournir le cœur de réseau destiné aux services NB-IoT et D2D par satellite à l’échelle mondiale
Mavenir Dipilih oleh Iridium untuk Menyediakan Jaringan Inti bagi Layanan NB-IoT dan D2D yang Berbasis Satelit Global
Mavenir נבחרה בידי Iridium לספק באופן גלובלי ליבת רשת לשירותי NB-IoT ו-D2D מבוססי לוויין
マベニア (Mavenir)、グローバル衛星ベースのNB-IoTおよびD2Dサービスのコアネットワーク提供のためにイリジウム (Iridium) により採用
Mavenir Dipilih oleh Iridium untuk Menyediakan Rangkaian Teras bagi Perkhidmatan NB-IoT dan D2D Berasaskan Satelit Global
Mavenir, Iridium 선택받아 글로벌 위성 기반 NB-IoT 및 D2D 서비스용 코어 네트워크 기술력 제공
Mavenir 获选为 Iridium 提供核心网络,支持全球基于卫星的 NB-IoT 及 D2D 服务
Mavenir 榮獲 Iridium 選定為全球衛星 NB-IoT 與 D2D 服務提供核心網絡
Mavenir Selecionada pela Iridium para Fornecer Rede Principal de Serviços Globais de NB-IoT e D2D Baseados em Satélite
Mavenir ได้รับการคัดเลือกจาก Iridium ให้จัดหาเครือข่ายแกนกลางสำหรับบริการ NB-IoT และ D2D…
Hash Hedge and Walbi launch the World Series of Crypto Trading (WSCT): the first global trading series with a live human vs AI final in Dubai
Sagimet Biosciences Announces Upcoming Panel Participation at Fierce Biotech Week
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
SCSK Corporation Joins SDVerse to Deliver Unique Mobility Solutions to a Global Market
Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions